Recent Quotes
My Watchlist
Indicators
Markets
Stocks
ETFs
Tools
Overview
News
Currencies
International
Treasuries

Telesis Bio, Inc. - Common Stock (NQ: TBIO )

3.400 UNCHANGED
Streaming Delayed Price Updated: 4:00 PM EDT, Aug 26, 2024 Add to My Watchlist
Quote
Overview Detailed Quote Charting Historical Prices
News
All News News Headlines Press Releases
Research
Quarterly Reports Insider Filings Other Filings

Price and Volume

Detailed Quote
Volume 1,071
Open 3.400
Bid (Size) 3.320 (1)
Ask (Size) 3.640 (1)
Prev. Close 3.400
Today's Range 3.400 - 3.400
52wk Range 3.025 - 25.20
Shares Outstanding 75,586,714
Dividend Yield N/A
Chart for (: )
Intraday 1 Week 1 Month 3 Month 1 Year 3 Year 5 Year

Top News

More News
TBIO Stock Earnings: Telesis Bio Misses EPS, Misses Revenue for Q2 2024
TBIO stock results show that Telesis Bio missed analyst estimates for earnings per share and missed on revenue for the second quarter of 2024. 
Via InvestorPlace
Telesis Bio Reports Second Quarter and First Half 2024 Financial Results
From Telesis Bio
Via GlobeNewswire

Performance

YTD
-52.03%
-52.03%
1 Month
-19.24%
-19.24%
3 Month
-4.68%
-4.68%
6 Month
-71.38%
-71.38%
1 Year
-83.86%
-83.86%

More News

Read More
Why AMD Shares Are Trading Higher By Over 9%; Here Are 20 Stocks Moving Premarket
Via Benzinga
Why ConAgra Brands Shares Are Trading Lower? Here Are Other Stocks Moving In Thursday's Mid-Day Session
Via Benzinga
Today’s Biggest Pre-Market Stock Movers: 10 Top Gainers and Losers on Thursday
Via InvestorPlace
12 Health Care Stocks Moving In Wednesday's Intraday Session
Via Benzinga
TBIO Stock Earnings: Telesis Bio Misses EPS, Misses Revenue for Q1 2024
Via InvestorPlace
Telesis Bio Reports First Quarter 2024 Financial Results
From Telesis Bio
Via GlobeNewswire
Telesis Bio Announces Reverse Stock Split
From Telesis Bio
Via GlobeNewswire
12 Health Care Stocks Moving In Thursday's After-Market Session
Via Benzinga
12 Health Care Stocks Moving In Wednesday's After-Market Session
Via Benzinga
Telesis Bio Inc. announces strategic focus on game-changing Gibson SOLA enzymatic DNA synthesis (EDS) platform and BioXp mRNA solutions and announces new leadership
From Telesis Bio
Via GlobeNewswire
12 Health Care Stocks Moving In Tuesday's After-Market Session
Via Benzinga
Today’s Biggest Pre-Market Stock Movers: 10 Top Gainers and Losers on Wednesday
Via InvestorPlace
12 Health Care Stocks Moving In Thursday's Pre-Market Session
Via Benzinga
Today’s Biggest Pre-Market Stock Movers: 10 Top Gainers and Losers on Thursday
Via InvestorPlace
TBIO Stock Earnings: Telesis Bio Misses EPS, Misses Revenue for Q4 2023
Via InvestorPlace
Telesis Bio Reports Fourth Quarter and Full Year 2023 Financial Results
From Telesis Bio
Via GlobeNewswire
12 Health Care Stocks Moving In Friday's Pre-Market Session
Via Benzinga
Why Cardlytics Shares Are Trading Higher By Around 37%; Here Are 20 Stocks Moving Premarket
Via Benzinga
12 Health Care Stocks Moving In Wednesday's After-Market Session
Via Benzinga
Why Helix Energy Solutions Shares Are Trading Lower By 11%? Here Are Other Stocks Moving In Tuesday's Mid-Day Session
Via Benzinga
12 Health Care Stocks Moving In Tuesday's Intraday Session
Via Benzinga
Why TransMedics Group Shares Are Trading Higher By Around 23%; Here Are 20 Stocks Moving Premarket
Via Benzinga
Stocks Making Waves: Insights into Key Developments and Potential VTAK, TBIO, OCEA, ONMD, KZIA
Via AB Newswire
Data & News supplied by www.cloudquote.io
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms and Conditions.